Prescription Monitoring and Drug Control Program Advisory on the PMP Regulations. The Advisory relates to the final promulgation of amendments to 105 CMR 700.000 (Implementation of M.G.L. c. 94C Controlled Substances Act) related to the use of the Prescription Monitoring Program and to 105 CMR 721.000 (Standards for Approved Prescription Forms in Massachusetts) Full Advisory, click here.